|
Xconomy
@
Xconomy
United States
|
|
Authoritative voice on biotech's exponential economy: news, events, awards, webinars, whitepapers, #Xconomists, #XceleratingLS, #XconBioRoundup, #XconXpertise
|
|
|
22.703
Tweetovi
|
2.300
Pratim
|
27.031
Osobe koje vas prate
|
| Tweetovi |
|
Xconomy
@Xconomy
|
54 min |
|
Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs
- by @sarahdc
xconomy.com/san-diego/2020… $ARQT
|
||
|
|
||
|
Xconomy
@Xconomy
|
1 h |
|
Here's the latest #XconBioRoundup:
xconomy.com/national/2020/…
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Frank Vinluan
@frankvinluan
|
1 h |
|
ICYMI, @aimmune won FDA approval Friday for #Palforzia, a peanut allergy therapy. The FDA decision covers kids 4-17 yrs.old... xconomy.com/san-francisco/… $AIMT
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Frank Vinluan
@frankvinluan
|
1. velj |
|
#Palforzia carries an $890 a month wholesale price before any rebates or discounts. But @aimmune says it will offer payment assistant programs that could reduce the cost to as low as $20 a month. The new drug is expected to launch in coming weeks.
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Medtech by @LaForge_AI
@Medtech_LaForge
|
19 h |
|
Xconomy: BIO Report: More Work Needed to Improve Diversity at Biotech Firms
#Diversity #biotech #diversityinSTEM
via @diversityup @cafepharma @Chefsache @Xconomy @_timos_
j.mp/36WkRLj pic.twitter.com/DnZ0NiufDQ
|
||
|
|
||
|
Xconomy
@Xconomy
|
31. sij |
|
BIO Report: More Work Needed to Improve Diversity at Biotech Firms
- by @sarahdc
xconomy.com/national/2020/…
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Frank Vinluan
@frankvinluan
|
31. sij |
|
When it comes to #CRISPR, size matters. Here's why @mammothbiosci thinks the smaller size of Cas14 gives it advantages for developing new drugs and diagnostics xconomy.com/san-francisco/…
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
[PARTNER EVENT] @NYCHBL presents 7th annual Healthcare Investment Trends: Where Will the Money Flow in 2020? Use code HCVC-PARTNER for $25 discount on registration. REGISTER: bit.ly/hcvc2020partner Sponsored by @BDOhealth #HCVC2020
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
Newly added #XconSD #XcelerateLS speakers include:
Ciara Kennedy of @AmplyxPharma
Chris Loryman of @UCSDInnovation
Russ Barrans of @Evofem
Josh Schimmer of Evercore
xconomy.com/xcelerating-li… pic.twitter.com/8zp9PZHaJx
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
With $45M, @mammothbiosci Expects Big Things From Tiny CRISPR Cas14
- by @frankvinluan; insight from CEO @martintrevor_
xconomy.com/san-francisco/…
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D
- by @frankvinluan
xconomy.com/boston/2020/01… $BDTX
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
Vizgen Launches With $14M to Market New Subcellular Imaging Technique
- by @sarahdc
xconomy.com/boston/2020/01…
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
Spun out the #XconomyAwards where Nancy Hopkins won the Lifetime Achievement Award, 3 @MIT scientists formed the Boston Biotech Working Group to "remedy the gender imbalance in biotech":
statnews.com/2020/01/29/bio… @snbhatia @SusanHockfield
|
||
|
|
||
|
Xconomy
@Xconomy
|
30. sij |
|
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins
- by @sarahdc
xconomy.com/new-york/2020/… $ANVS
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Dan Stanton
@Dan5tanton
|
30. sij |
|
Lack of good #CDMOs a factor for @KrystalBiotech in investing $70-90m into internal PA gene therapy plant buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
EBD Group
@EBDgroup
|
29. sij |
|
Calling all #Starups 📢 Are you looking to engage with #biopharma executives and #investors? Apply to pitch at this year’s Startup Spotlight during #BIOEuropeSpring. The deadline to apply is this Friday, January 31! >> ebdgroup.formstack.com/forms/?3673559… pic.twitter.com/EL0sfhPySc
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Frank Vinluan
@frankvinluan
|
29. sij |
|
This @AcceleronPharma drug didn't pan out treating a rare blood disorder or chronic kidney disease. But with positive topline Phs 2 data in #pulmonaryarterialhypertension, some now see blockbuster potential. $XLRN shares shot up 50% Tues. xconomy.com/boston/2020/01… #PAH
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Biotech Week Boston
@BiotechWkBoston
|
29. sij |
|
When developing a new therapy how do you keep in complete control of its manufacturing? This whitepaper looks at what to consider - whatever path you take.
spr.ly/601015Ham
|
||
|
|
||
| Xconomy proslijedio/la je tweet | ||
|
Big4Bio:Philly
@Big4BioPhilly
|
29. sij |
|
Attend the 14th Annual Hub and SPP Model Optimization event, which will feature manufacturers, pharmacies, PBMs and more, on February 24-26, 2020, at the Loews Philadelphia Hotel.
Register today!
@InformaConnect
#conference
informaconnect.com/hub-and-spp-mo…
|
||
|
|
||
|
Xconomy
@Xconomy
|
29. sij |
|
.@SpringBankPharm Ends Hepatitis B Work After Death in Clinical Trial
- by @frankvinluan
xconomy.com/boston/2020/01… $SBPH
|
||
|
|
||